Cognitive Performance Predicting fMRI Brain Activation in Healthy Adults

2010 ◽  
Author(s):  
Rowena G. Gomez ◽  
Jennifer Keller ◽  
Linda J. Trettin ◽  
Andrea Che ◽  
Eric S. Rogers ◽  
...  
2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Orwa Dandash ◽  
Nicolas Cherbuin ◽  
Orli Schwartz ◽  
Nicholas B. Allen ◽  
Sarah Whittle

AbstractParenting behavior has a vital role in the development of the brain and cognitive abilities of offspring throughout childhood and adolescence. While positive and aggressive parenting behavior have been suggested to impact neurobiology in the form of abnormal brain activation in adolescents, little work has investigated the links between parenting behavior and the neurobiological correlates of cognitive performance during this age period. In the current longitudinal fMRI study, associations between parenting behaviors and cognitive performance and brain activation across mid- and late-adolescence were assessed. Observed measures of maternal aggressive and positive behavior were recorded in early adolescence (12 years) and correlated with fMRI activation and in-scanner behavioral scores on the multi-source interference task (MSIT) during mid- (16 years; 95 participants) and late-adolescence (19 years; 75 participants). There was a significant reduction in inhibitory-control-related brain activation in posterior parietal and cingulate cortices as participants transitioned from mid- to late-adolescence. Positive maternal behavior in early-adolescence was associated with lower activation in the left parietal and DLPFC during the MSIT in mid-adolescence, whereas maternal aggressive behavior was associated with longer reaction time to incongruent trials in late-adolescence. The study supports the notion that maternal behavior may influence subsequent neurocognitive development during adolescence.


2010 ◽  
Vol 182 (2) ◽  
pp. 123-133 ◽  
Author(s):  
Cecilie Bhandari Hartberg ◽  
Glenn Lawyer ◽  
Håkan Nyman ◽  
Erik G. Jönsson ◽  
Unn K. Haukvik ◽  
...  

Nutrients ◽  
2013 ◽  
Vol 5 (9) ◽  
pp. 3589-3604 ◽  
Author(s):  
Andrew Scholey ◽  
Isabelle Bauer ◽  
Chris Neale ◽  
Karen Savage ◽  
David Camfield ◽  
...  

2018 ◽  
Vol 24 (C) ◽  
pp. 95
Author(s):  
Telmo Pereira ◽  
Jacqueline Bergqvist ◽  
Bente Sveälv ◽  
Joaquim Castanheira ◽  
Jorge Conde

2019 ◽  
Vol 64 ◽  
pp. S305-S306
Author(s):  
F.B. Pomares ◽  
N. Cross ◽  
A. Jegou ◽  
A. Nguyen ◽  
A.A. Perrault ◽  
...  

2019 ◽  
Vol 2 (2) ◽  
pp. 171-182
Author(s):  
Fanaras Konstantinos ◽  
Reinhard Heun

AbstractObjectivesGuarana (Paullinia cupana) from the Sapindaceae family, native to the Amazon basin, is a natural stimulant herb that can be found in popular energy drinks, pharmaceutical shops or local herb shops. With the use of natural health products increasing, guarana has gained a fair amount of popularity in the past years. In this systematic review, we examined the effects of guarana supplementation on cognitive performance. A secondary objective was to compare guarana with caffeine on cognitive performance.MethodsSearches were made in PubMed using the terms ‘Guarana’ or ‘Paullinia cupana’. Filters focused on Controlled Clinical trials. Inclusion criteria were met by studies using interventions with guarana, while focusing on guarana’s effects on cognition. Participants needed to be young, healthy adults. Studies not published in English or Greek were excluded. The last date of our search was March 7, 2019.ResultsA total of 29 studies were identified and screened. After screening, 17 studies were excluded. The remaining 12 studies were found eligible for data extraction. After reading the full text of the 12 studies, 3 studies were excluded. In the end, 9 studies were found eligible for our systematic review (n = 369 participants). In these studies, guarana showed to improve reaction time and accuracy of performance at cognitive tasks. No significant differences were found when comparing guarana with caffeine.ConclusionGuarana seems to improve reaction time and accuracy of performance at tasks, but no significant effects were found when compared with caffeine. High quality randomized controlled clinical trials with a low risk of bias are needed to further study the herb.


2010 ◽  
Vol 25 (8) ◽  
pp. 1088-1100 ◽  
Author(s):  
David O Kennedy ◽  
Fiona L Dodd ◽  
Bernadette C Robertson ◽  
Edward J Okello ◽  
Jonathon L Reay ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document